Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia and Disorders With Psychotic Feature”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01530529
What this trial is testing

Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999

Who this might be right for
Healthy
Pfizer 12
Not applicableUnknownNCT00791882
What this trial is testing

Social Skills Training in Refractory Schizophrenia

Who this might be right for
Schizophrenia and Disorders With Psychotic Features
University of Sao Paulo 92
Testing effectiveness (Phase 2)Study completedNCT06356389
What this trial is testing

A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia.

Who this might be right for
Schizophrenia
Zhejiang Jingxin Pharmaceutical Co., Ltd. 60
Not applicableNot Yet RecruitingNCT07820553
What this trial is testing

Building a Computational Model of Auditory Hallucinations

Who this might be right for
Schizophrenia / Schizoaffective DisorderSchizophrenia and Disorders With Psychotic FeaturePsychosis+2 more
King's College London 146
Large-scale testing (Phase 3)Ended earlyNCT00637494
What this trial is testing

Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Who this might be right for
Psychotic DepressionSevere Major Depression With Psychotic FeaturesPsychosis
Corcept Therapeutics 292
Not applicableStudy completedNCT01570972
What this trial is testing

Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder With Psychotic Features+2 more
University of Arizona 103
Not applicableStudy completedNCT01866098
What this trial is testing

Naltrexone for Antipsychotic-Induced Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Yale University 144
Not applicableStudy completedNCT01995864
What this trial is testing

Critical Time Intervention-Task Shifting: Randomized Controlled Trial

Who this might be right for
SchizophreniaPsychotic Disorder
Columbia University 110
Large-scale testing (Phase 3)Study completedNCT00208156
What this trial is testing

A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Depressive Disorder, Major
Corcept Therapeutics 87
Testing effectiveness (Phase 2)Study completedNCT01259427
What this trial is testing

Reducing Internalized Stigma in People With Serious Mental Illness

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+1 more
VA Office of Research and Development 252
Testing effectiveness (Phase 2)Looking for participantsNCT06939088
What this trial is testing

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

Who this might be right for
Alcohol Use DisorderAlcohol Abuse/DependenceAlcohol Dependence+5 more
Anders Fink-Jensen, MD, DMSci 108
Not applicableStudy completedNCT00695708
What this trial is testing

Training-induced Cerebral Reorganization in Schizophrenia

Who this might be right for
Schizophrenia
University of Konstanz 60
Large-scale testing (Phase 3)Study completedNCT00128479
What this trial is testing

A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 443
Not applicableStudy completedNCT02484521
What this trial is testing

Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration

Who this might be right for
Inhibition (Psychology)SchizophreniaMedication Adherence
HaEmek Medical Center, Israel 31
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Not applicableStudy completedNCT00980252
What this trial is testing

Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention

Who this might be right for
SchizophreniaPsychotic Disorders
University of Illinois at Chicago 34
Not applicableStudy completedNCT00309452
What this trial is testing

Specialized Treatment Early in Psychosis (STEP)

Who this might be right for
Schizophrenia and Disorders With Psychotic Features
Yale University 120
Large-scale testing (Phase 3)Study completedNCT00102518
What this trial is testing

Aripiprazole Open-Label, Safety and Tolerability Study

Who this might be right for
SchizophreniaBipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 325
Not applicableStudy completedNCT01160679
What this trial is testing

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 231
Not applicableStudy completedNCT00135772
What this trial is testing

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2

Who this might be right for
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use Disorder
National Institute on Drug Abuse (NIDA) 100
Next Page